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ROS	  plays	  three	  main	  roles	  in	  the	  cell:	  it	  is	  a	  (i)	  signalling	  
molecule	  in	  cell	  diﬀeren@a@on,	  (ii)	  “killing”	  ingredient	  in	  
immune	  response,	  and	  (iii)	  damaging	  component	  leading	  to	  
undesired	  cell	  death.	  The	  precise	  tuning	  of	  ROS	  management	  
is	  crucial	  in	  cell	  func@oning.	  
Parkinson’s	  disease	  (PD)	  is	  an	  example	  of	  ROS-­‐related	  
neurodegenera@ve	  disorders,	  aﬀec@ng	  1–3%	  of	  the	  
popula@on	  over	  65	  years	  of	  age.	  PD	  is	  characterised	  by	  
motoric	  disorders	  and	  is	  caused	  by	  the	  death	  of	  
dopaminergic	  neurons	  in	  the	  substan'a	  nigra	  -­‐	  a	  brain	  
structure	  located	  in	  the	  mesencephalon	  (midbrain).	  
Dopaminergic	  neurons	  need	  a	  lot	  of	  energy	  to	  secrete	  
dopamine.	  Thus,	  dopaminergic	  neurons	  have	  a	  higher	  level	  
of	  oxida@ve	  phosphoryla@on	  and	  produce	  more	  ROS.	  	  
ROS	  management	  network	  is	  a	  good	  example	  of	  a	  non-­‐linear	  
mul@-­‐component	  system	  which	  is	  too	  complex	  for	  intui@ve	  
understanding	  and	  needs	  more	  advanced	  systems	  biological	  
approaches.	  	  
We	  propose	  a	  detailed,	  mechanis@c,	  dynamic	  model	  of	  ROS	  
management.	  Our	  model	  oﬀers	  insight	  into	  the	  design	  principles	  
underlying	  the	  func@onality	  of	  ROS	  homeostasis	  and	  enlightens	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Detailed model of ROS management 
Parkinson’s disease: How to save a neuron 
An emergent behaviour:  
Response to the increased ROS generation 
PD: increased α-synuclein PD: DJ1 is knocked down 
PD: α-synuclein and Keap1 are up, 
Pink1, DJ1 and VDAC1 are down Healthy 
Untreated Untreated Untreated 
Nrf2 synthesis is 
activated 50 fold 
Nrf2 synthesis is 
activated 1000 fold 
Nrf2 synthesis is 
activated 1000 fold 
Activation of Nrf2 synthesis (e.g. by caffeine)  
might help 
Proposed example of personalised medicine: PD-related increase of α-synuclein might be compensated by Nrf2 activation. 
However, Nrf2 activation does not help if PD is caused by DJ1 knockdown or other mutations.    
Activation of Nrf2 synthesis (e.g. by caffeine)  does not help 
Mechanism explaining why does it happen: 
System allows to compensate stress (increased ROS generation) in 
the short term. However, in the long term, system collapses. 
